Eli Lilly has outstanding growth prospects thanks to its leadership in its core therapeutic area. AbbVie’s immunosuppressant portfolio helps it to produce steady revenue and profits.
Source: https://www.fool.com/investing/2026/01/19/best-healthcare-st…
LAND, NABZY and F made it to the Zacks Rank #1 (Strong Buy) income stocks list on Jan.13, 2026.
The first company on this list is already crushing it in the AI race, as it’s involved in seemingly every area related to the technology. With billions of daily active users, the second business has one of the most powerful network effects on the face of the planet.
The Strait of Hormuz disruption could keep oil prices elevated longer than a typical supply shock due to shipping/insurance constraints, limited SPR flexibility, and already-tightening fundamentals. ExxonMobil and Devon Energy could translate higher oil into outsized free cash flow, including Exxon’s advantaged production and LNG ramp and Devon’s Coterra merger synergies plus a potential dividend step-up.
